Lumiblast™

A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumors Background Glioblastoma is an aggressive brain cancer and one example of deep-lying tumors that are difficult to access and treat with current...

A versatile improved antibody Fc technology platform

Business opportunity Inventors at the University of Oslo/Oslo University hospital have developed a unique and versatile antibody Fc technology platform (“REW”). The technology increases the serum half-life and biodistribution properties of IgG antibodies and Fc...